Neutral lipid biosynthetic process

pathway activity — cross-omics
GO:0046460Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Neutral lipid biosynthetic process pathway is significantly associated with the RNA expression of multiple genes, with the GBM cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are DRAM1, HLA-DQB1-AS1, and SCHIP1, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Neutral lipid biosynthetic process activity versus DRAM1 in GBM (Pearson r = 0.24).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
GBMDRAM1 →+0.409+0.205.001<.00134
GBMHLA-DQB1-AS1 →+0.761+0.148.002.00734
CCRCCSCHIP1 →-0.506-0.221.005.00534
GBMGMFG →+0.673+0.193<.001.00233
LSCCBATF3 →+0.356+0.192.001.00233
LSCCKATNBL1 →-0.417-0.198<.001<.00133
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0046460 vs DRAM1 — GBM

Per-sample scatter of Neutral lipid biosynthetic process activity vs DRAM1 in GBM.

Explore this scatter interactively →

Exploration